Live Breaking News & Updates on மொழிபெயர்ப்பு அறிவியல் விருது
Stay updated with breaking news from மொழிபெயர்ப்பு அறிவியல் விருது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
by Michela Kane May 25, 2021 . DURHAM – Smartwatches and other wearable devices may be used to sense illness, dehydration and even changes to the red blood cell count, according to biomedical engineers and genomics researchers at Duke University and the Stanford University School of Medicine. The researchers say that, with the help of machine learning, wearable device data on heart rate, body temperature and daily activities may be used to predict health measurements that are typically observed during a clinical blood test. The study appears in Nature Medicine on May 24, 2021. During a doctor’s office visit, a medical worker usually measures a patient’s vital signs, including their height, weight, temperature and blood pressure. Although this information is filed away in a person’s long-term health record, it isn’t usually used to create a diagnosis. Instead, physicians will order a clinical lab, which tests a patient’s urine or blood, to gather specific ....
E-Mail Credit: Michaela Kane, Duke University DURHAM, N.C. Smartwatches and other wearable devices may be used to sense illness, dehydration and even changes to the red blood cell count, according to biomedical engineers and genomics researchers at Duke University and the Stanford University School of Medicine. The researchers say that, with the help of machine learning, wearable device data on heart rate, body temperature and daily activities may be used to predict health measurements that are typically observed during a clinical blood test. The study appears in Nature Medicine on May 24, 2021. During a doctor s office visit, a medical worker usually measures a patient s vital signs, including their height, weight, temperature and blood pressure. Although this information is filed away in a person s long-term health record, it isn t usually used to create a diagnosis. Instead, physicians will order a clinical lab, which tests a patient s urine or blood, ....
Share this article TUCSON, Ariz., May 19, 2021 /PRNewswire/ Critical Path Institute (C-Path) today announced the appointment of Robert M. Califf, MD, MACC, head of Clinical Policy and Strategy for Google parent company Alphabet s Verily Life Sciences and Google Health divisions, to C-Path s Board of Directors. Califf served as the U.S. Food and Drug Administration (FDA) Commissioner under President Barack Obama s administration from 2016-2017. Robert M. Califf, MD, MACC A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature. ....
C-Path Welcomes Alphabet Clinical Policy and Strategy Head, Former FDA Commissioner to Board prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.